替硝唑在肺部感染患者体内的药物动力学
投稿时间:2000-04-25    点此下载全文
引用本文:贾暖,刘俊,卞艳芳,袁成.替硝唑在肺部感染患者体内的药物动力学[J].药学实践杂志,2000,(6):372~374
摘要点击次数: 1062
全文下载次数: 865
作者单位
贾暖  
刘俊  
卞艳芳  
袁成  
中文摘要:目的 测定肺部感染患者静脉注射替硝唑的药物动力学。方法 采用反相高效液相色谱法测定血清中替硝唑的浓度,以甲硝唑为内标,水-乙腈-醋酸(80:20:01)为流动相,在1~50mg/L范围内线性关系良好,最低检测限0.1mg/L.7名住院肺部感染患者静脉滴注替硝唑葡萄糖注射液400mg,90min内滴完。于滴注前和滴注后取患者对侧上肢静脉血2ml测定。结果 药-时曲线符合二室开放模型,有关药动学参数分别为T1/2α=(2.42±1.75)h,T1/2β=(14.20±4.00)h,AUC0~∞=(219.0±83.9)mg.h/L,Vc=(26.58±11.75)L.结论 肺部感染患者静注替硝唑的药物动力学个体差异较大。
中文关键词:替硝唑  药物动力学  反相高效液相色谱法
 
Pharmacokinetics of tinidazole in patients with lung infection
Abstract:OBJECTIVE To determine pharmacokinetics of tinidazole in patients with lung infection.METHODS The concentration of tinidazole in patients'serum was determined by a RP-HPLC method.Metronidazole was being internal standard and a mobile phase of wateracetonitrile-acetic acid(80:20:0 1) were used.There was a good liner relation within the range of 1~50mg/L and the determination limit was 0 1mg/L.Of these patients,5 males and 2 females,were driped intravenously 400mg of tinidazole within 90min.RESULTS The results suggested the pharmacokinetics of administrated tinidazole could be described by a linear two-compartment model.The pharmacokinetic parameters were T1/2α=(2.42±1.75)h,T1/2β=(14.20±4.00)h,AUC0~∞=(219.0±83.9)mg.h/L,Vc=(26.58±11.75)L. CONCLUSIONS There was marker difference for pharmacokinetics of tinidazole among the 7 patients.
keywords:tinidazole  pharmacokinetics  RP-HPLC
查看全文  查看/发表评论  下载PDF阅读器
关闭

分享按钮